A novel biomarker-based tool to monitor multiple sclerosis evolution at clinical and sub-clinical stages: Antibody-proteases as a new generation of translational tools to monitor, to predict and to prevent demyelination
Subclinical multiple sclerosis (S-MS) can be usually defined as the discovery of characteristic lesions at magnetic resonance (MR) or at autopsy, in the absence of clinical evidence con-sistent ... diagnosis of…

